EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Mechanistic characterization of norjuziphine–β-lactoglobulin nanocomplexes: Protein conformational remodeling governs encapsulation and therapeutic effects in human hepatocellular carcinoma cells

Qing Cen, Wei Wang, Jie Pan, Haibo He, Weifeng Teng, Jingzhi Wang, Zhibin Bai

European Journal of Pharmaceutical Sciences · 2026-12 · 227 · 107656

DOI: 10.1016/j.ejps.2026.107656 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmaceutical Sciences, 2026-12. Verfasst von Qing Cen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Cixi People's Hospital, Wenzhou Medical University, Ningbo, Zhejiang, 315300, China. Hauptthemen laut MEDLINE: Lactoglobulins, Carcinoma, Hepatocellular, Liver Neoplasms, Antineoplastic Agents. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of protein-based systems capable of delivering bioactive compounds remains an important challenge in pharmaceutical formulation science. In this study, β-lactoglobulin (βLG) was investigated as a biocompatible nanocarrier for norjuziphine, 1-[(4-hydroxyphenyl)methyl]-7‑methoxy-1,2,3,4-tetrahydroisoquinolin-8-ol. The binding mechanism, protein structural changes, physicochemical characteristics, drug-release behavior, and biological performance of norjuziphine-βLG nanocomplexes were comprehensively characterized. Fluorescence quenching studies demonstrated spontaneous static complex formation with binding constants in the range of 105-106 L mol-1. Spectroscopic, calorimetric, and computational analyses consistently showed ligand-induced conformational remodeling and stabilization of βLG. The resulting nanocomplexes exhibited semi-spherical morphology with a mean hydrodynamic diameter of 190.1 ± 10.34 nm and an encapsulation efficiency of approximately 79.0%. In vitro release studies demonstrated controlled drug release behavior with moderate pH dependence. Nanoencapsulation increased intracellular norjuziphine accumulation by approximately 2.3-fold relative to free norjuziphine and was associated with enhanced antiproliferative activity in human hepatocellular carcinoma (HCC) cells, a reduced IC50 value (15.3 ± 2.33 μM), and significant regulation of Bax, Bcl-2, and Caspase-3 expression. Collectively, these findings establish a mechanistic relationship between hydrophobic interaction-driven complexation, protein conformational remodeling, and delivery performance, highlighting β-lactoglobulin as a promising protein-based carrier for improving the delivery of bioactive compounds.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LactoglobulinsCarcinoma, HepatocellularLiver NeoplasmsAntineoplastic AgentsDrug CarriersNanoparticlesHumansDrug LiberationProtein ConformationHep G2 CellsApoptosisCell SurvivalProto-Oncogene Proteins c-bcl-2Cell Line, Tumorbcl-2-Associated X ProteinCaspase 3

Stichwörter der Autor:innen

Cellular uptakeMolecular interactionsNorjuziphineProtein-based nanocarrierβ-lactoglobulin

Substanzen

LactoglobulinsAntineoplastic AgentsDrug CarriersProto-Oncogene Proteins c-bcl-2bcl-2-Associated X ProteinCaspase 3

Autor:innen und Institutionen

  • Department of General Surgery, Cixi People's Hospital, Wenzhou Medical University, Ningbo, Zhejiang, 315300, China.
  • Pingyang Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325400, China.
  • Cixi Biomedical Research Institute, Wenzhou Medical University, Ningbo, Zhejiang, 315300, China.
  • Department of Radiotherapy Oncology, The First People's Hospital of Yancheng, Yancheng No.1 People's Hospital, Affiliated Hospital of Medical School, Nanjing University, Yancheng, 224000, China. Electronic address: 8411…
  • Pingyang Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325400, China. Electronic address: 19588118088@163.com.

Zitieren

APA

Cen, Q., Wang, W., Pan, J., He, H., Teng, W., Wang, J., & Bai, Z. (2026). Mechanistic characterization of norjuziphine–β-lactoglobulin nanocomplexes: Protein conformational remodeling governs encapsulation and therapeutic effects in human hepatocellular carcinoma cells. European Journal of Pharmaceutical Sciences, 227, 107656. https://doi.org/10.1016/j.ejps.2026.107656

Vancouver

Cen Q, Wang W, Pan J, He H, Teng W, Wang J, et al. Mechanistic characterization of norjuziphine–β-lactoglobulin nanocomplexes: Protein conformational remodeling governs encapsulation and therapeutic effects in human hepatocellular carcinoma cells. European Journal of Pharmaceutical Sciences. 2026;227:107656. doi:10.1016/j.ejps.2026.107656

BibTeX
@article{Cen2026,
  author = {Cen, Qing and Wang, Wei and Pan, Jie and He, Haibo and Teng, Weifeng and Wang, Jingzhi and Bai, Zhibin},
  title = {Mechanistic characterization of norjuziphine–β-lactoglobulin nanocomplexes: Protein conformational remodeling governs encapsulation and therapeutic effects in human hepatocellular carcinoma cells},
  journal = {European Journal of Pharmaceutical Sciences},
  year = {2026},
  volume = {227},
  pages = {107656},
  doi = {10.1016/j.ejps.2026.107656}
}
Kostenlos starten →